| 111186-25G |
|
151213-40-0 |
(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
≥98%,-
|
25G |
C7H14N2 |
|
|
|
| 111186-5G |
|
151213-40-0 |
(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
≥98%,-
|
5G |
C7H14N2 |
|
|
|
| 111186-1G |
|
151213-40-0 |
(1S,6S)-2,8-Diazabicyclo[4.3.0]nonane
≥98%,-
|
1G |
C7H14N2 |
|
|
|
| 111170-1G |
|
186826-86-8(Component:151096-09-2) |
Moxifloxacin Hydrochloride
≥98%,-
|
1G |
C21H24FN3O4·HCl |
|
|
|
| 135648-1G |
|
50-07-7 |
|
1G |
C15H18N4O5 |
|
|
|
| 135648-100MG |
|
50-07-7 |
|
100MG |
C15H18N4O5 |
|
|
|
| 111160-25G |
|
137862-53-4 |
|
25G |
C24H29N5O3 |
|
|
|
| 111160-5G |
|
137862-53-4 |
|
5G |
C24H29N5O3 |
|
|
|
| 111152-1G |
|
142217-69-4 |
|
1G |
C12H15N5O3 |
|
|
|
| 111152-500MG |
|
142217-69-4 |
|
500MG |
C12H15N5O3 |
|
|
|
| 111142-25G |
|
139306-10-8 |
3-[(S)-1-(N,N-Dimethylamino)ethyl]phenol
≥98%,99%e.e.
|
25G |
C10H15NO |
|
|
|
| 111142-5G |
|
139306-10-8 |
3-[(S)-1-(N,N-Dimethylamino)ethyl]phenol
≥98%,99%e.e.
|
5G |
C10H15NO |
|
|
|
| 111142-1G |
|
139306-10-8 |
3-[(S)-1-(N,N-Dimethylamino)ethyl]phenol
≥98%,99%e.e.
|
1G |
C10H15NO |
|
|
|
| 111132-25G |
|
132335-44-5 |
(S)-3-(Dimethylamino)-1-(2-thienyl)-1-propanol
≥98%,99%e.e.
|
25G |
C9H15NOS |
|
|
|
| 111132-5G |
|
132335-44-5 |
(S)-3-(Dimethylamino)-1-(2-thienyl)-1-propanol
≥98%,99%e.e.
|
5G |
C9H15NOS |
|
|
|
| 111132-1G |
|
132335-44-5 |
(S)-3-(Dimethylamino)-1-(2-thienyl)-1-propanol
≥98%,99%e.e.
|
1G |
C9H15NOS |
|
|
|
| 111116-1G |
|
197658-50-7 |
(3S)-3-[[(S)-1-Phenylethyl]amino]-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
≥98%,99%e.e.
|
1G |
C18H20N2O |
|
|
|
| 111115-1G |
|
NA |
(3R)-3-[[(R)-1-Phenylethyl]amino]-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
≥98%,99%e.e.
|
1G |
C18H20N2O |
|
|
|
| 100152-1G |
|
531-95-3 |
(S)-Equol;
(3S)-3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol
≥98%,99%e.e.
|
1G |
C15H14O3 |
|
|
|
| 100151-1G |
|
221054-79-1 |
(R)-Equol;
(3R)-3,4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol
≥98%,99%e.e.
|
1G |
C15H14O3 |
|
|
|
